Welcome back to the 52-week Series – A recap of ASX 200 stocks marking yearly highs and lows in the past week.
Materials: 3 Highs, 3 Lows
Healthcare: 2 Highs, 1 Low
Industrials: 1 High ,1 Low
Technology: 1 High, 0 Lows
Discretionary: 0 Highs, 2 Low
Staples: 0 Highs, 1 Low
Financials: 0 Highs, 2 Lows
Real Estate, Communications, Utilities and Energy: 0 Highs, 0 Lows
Ticker | Company | Close Price | Sector | 1 Week | 1 Year |
---|---|---|---|---|---|
Neuren Pharmaceuticals | $14.90 | Health Care | 1.50% | 81.49% | |
James Hardie | $46.81 | Materials | -2.70% | 55.67% | |
Seven Group | $31.94 | Industrials | 1.62% | 55.05% | |
Pro Medicus | $88.08 | Health Care | 0.62% | 48.41% | |
Fortescue | $25.03 | Materials | -0.75% | 32.15% | |
Data#3 | $7.74 | Technology | 2.65% | 13.82% | |
Deterra Royalties | $5.03 | Materials | -1.18% | 12.53% |
52-week highs of interest:
James Hardie: Homebuilder stocks spent most of this year ripping higher before a sharp 10-20% pullback between early September and late October. The below chart shows the performance of the SPDR Homebuilders ETF and its V-shaped its way back up to recent highs – The ETF can be used as a barometer for stocks like James Hardie (which generates a majority of its revenue from the US) and to a lessor extent, names like CSR and Boral.
Seven Group: Seven has experienced a similar dip and rip narrative. This move was further supported by an earnings upgrade at its AGM on November 16 where management said they expect to see "high single to low teen EBIT growth" for FY24, up from "high single-digit EBIT growth."
Pro Medicus: Founders Anthony Hall and Sam Hupert sold a combined $176 million worth of shares last Tuesday but for good reason. "The sale was in response to a strong approach from an individual fund and was done before market at the previous day’s closing price," the company said in a statement. The sale was done at a zero percent discount, which means the fund was happy to buy an outsized amount on-market. It clearly doesn't mind buying the stock at today's prices despite its 60% year-to-date rally and 152 price-to-earnings ratio.
The 52-week low list is populated by several underperformers that have been consistently setting new yearly lows, such as AMP, IGO, Alumina, Link Administration, Chalice Mining, and The Star.
Ticker | Company | Close Price | Sector | 1 Week | 1 Year |
---|---|---|---|---|---|
Steadfast Group | $5.50 | Financials | 5.16% | 2.80% | |
Challenger | $5.79 | Financials | 0.52% | -19.58% | |
Treasury Wine Estates | $10.59 | Staples | -0.19% | -21.09% | |
Tabcorp | $0.74 | Discretionary | -1.99% | -28.50% | |
AMP | $0.91 | Financials | 6.43% | -31.58% | |
IGO | $8.74 | Materials | -1.80% | -41.93% | |
Alumina | $0.71 | Materials | -0.70% | -54.52% | |
Healius | $1.30 | Health Care | -23.46% | -58.32% | |
Link Administration | $1.19 | Industrials | 0.85% | -66.57% | |
Chalice Mining | $1.47 | Materials | -6.07% | -72.26% | |
The Star Entertainment | $0.50 | Discretionary | -10.71% | -78.41% |
Get the latest news and insights direct to your inbox